MeSH tree: D12.776.543.550.147
Australian researchers have uncovered a critical mechanism driving the growth and spread of glioblastoma—one of the most aggressive and lethal forms of brain cancer—potentially paving the way for more effective treatments. ...
Mar 23, 2026
0
24
Researchers from The University of Texas MD Anderson Cancer Center have found that simultaneously blocking two key "don't eat me signals" found in cancer cells heightens the immune response and sensitizes tumors to immunotherapy ...
Mar 13, 2026
0
5
Metastasis occurs when cancer cells break away from the original tumor and travel through the bloodstream to form new tumors in other parts of the body. It is the leading cause of cancer-related death. Brain metastasis is ...
Dec 10, 2025
0
22
A new study has discovered a molecular signal that tumors exploit to exhaust the T cells meant to destroy them—and how silencing that signal could revive the body's immunity.
Nov 17, 2025
0
96
A study led by André Veillette, a researcher at the Montreal Clinical Research Institute (IRCM) and a professor in the Faculty of Medicine at University of Montreal, sheds new light on the complexity of the immune system ...
Nov 5, 2025
0
21
In a new study published in Nature, researchers at the University of Chicago Medicine Comprehensive Cancer Center explore a surprising phenomenon in which high doses of radiation cause growth in existing metastatic tumors ...
May 14, 2025
0
50
Immune checkpoint inhibitors, a class of immunotherapies that help immune cells attack cancer more effectively, have revolutionized cancer treatment. However, fewer than 20% of patients respond to these treatments, highlighting ...
Apr 8, 2025
0
26
Researchers at the University of Texas MD Anderson Cancer Center have developed a novel antibody-toxin conjugate (ATC) designed to stimulate immune-mediated eradication of tumors. According to preclinical results published ...
Feb 25, 2025
0
47
Researchers, led by the University of Melbourne's Professor Laura Mackay, a Laboratory Head and Immunology Theme Leader at the Peter Doherty Institute of Infection and Immunity (Doherty Institute), in collaboration with Pfizer, ...
Feb 12, 2025
0
20
Pancreatic cancer patients may benefit from future precision treatments as a new study shows how some tumors may potentially be more susceptible to macrophage-based therapies.
Feb 7, 2025
0
41
